2012
DOI: 10.1007/s12663-011-0318-6
|View full text |Cite
|
Sign up to set email alerts
|

OraVerse: Reverses Numbness After Dental Procedures

Abstract: The lingering numbness that can last anywhere from 3 to 5 h after a routine dental procedure is often an unnecessary, inconvenient hassle. Patients may find that their ability to speak, smile, eat and drink is impaired, and may even have uncontrollable drooling. The effects of local dental anesthetics can now be reversed. That's because OraVerse, an anesthetic reversal agent, can return the patient to normal sensation and function in about half the time. OraVerse which is U.S. Food and Drug Administration appr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 12 publications
0
14
0
Order By: Relevance
“…Phentolamine mesylate is a safe, injectable solution, packaged in individual cartridges and approved by the Food and Drug Administration for the reversal of anesthesia in the lips and tongue after use of LA-containing vasoconstrictors [5][6][7][8][9][10][11][12]. This drug has been previously used to aid the diagnosis of pheochromocytoma and treat erectile dysfunction, dermal necrosis, and several hypertension conditions [8,13,14].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Phentolamine mesylate is a safe, injectable solution, packaged in individual cartridges and approved by the Food and Drug Administration for the reversal of anesthesia in the lips and tongue after use of LA-containing vasoconstrictors [5][6][7][8][9][10][11][12]. This drug has been previously used to aid the diagnosis of pheochromocytoma and treat erectile dysfunction, dermal necrosis, and several hypertension conditions [8,13,14].…”
Section: Introductionmentioning
confidence: 99%
“…However, phentolamine mesylate is a pregnancy risk category C drug, and whether the drug is secreted in breast milk in lactating patients is unknown. Therefore, its use is generally avoided to prevent potential adverse effects [12].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…OraVerse is not indicted for children aged less than 6 years, or weighing less than 15 kg. It is also inadviseable to use it after invasive surgical procedures or endodontic treatments, where post-operative discomfort is expected [27].…”
Section: Gow-gates Nerve Blockmentioning
confidence: 99%
“…Furthermore, Phentoaminemesylate breaks down through liver and the kidneys, so some adverse side-effects might occur like: Diarrhea, facial swelling, increased blood pressure or hypertension, reactions to injection site, jaw pain, oral pain, paresthesia, pruritus, tenderness, upper abdominal pain and vomiting. [ 16 ]…”
Section: Introductionmentioning
confidence: 99%